475 results
TechNet Admin
Robert Steinglass, Frances Mwansa, Guissimon Phiri, Wendy Prosser, Natasha Kanagat, Ali Karim, Barbara Knittel, Kirstin Krudwig
Abstract Introduction Vaccines procured for low-income countries are often packaged in multi-dose vials to reduce program costs. To avoid wastage, health workers may refrain from opening a vial if...
UNICEF
The product menu provides an overview of the most recent and historical data on Gavi-supported vaccine products that UNICEF procures on behalf of countries.
UNICEF
The document provides an overview of prices per vaccine contracted by UNICEF with suppliers.
UNICEF
This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.
UNICEF
This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.
UNICEF
The table shows the awarded price per dose (in US$) per product per supplier per calendar year, based on a multi year supply agreement.
UNICEF
The table shows the awarded price per dose (in US$) per product per supplier per calendar year, based on a multi year supply agreement.
UNICEF
This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.
Hamadou M. Dicko, Elise Guillermet, Le Thi Phuong Mai, Mamadou N’Diaye, Fatoumata Hane, Seydina Ousmane Ba, Khadidjatou Gomis, Nguyen Thi Thi Tho, Nguyen Thi Phuong Lien, Phan Dang Than, Tran Van Dinh, Philippe Jaillard, Bradford D. Gessner, Anais Colombini
Prefilled syringes are the standard in developed countries but logistic and financial barriers prevent their widespread use in developing countries. The current study evaluated use of a compact,...
Fox et al.
This collection seeks to elucidate the practical methods necessary for successful adjuvant development, with a particular focus on the synthesis, formulation, manufacturing, and characterization...
Grace Mwangoka, Bernhards Ogutu, Beverly Msambichaka, , Tutu Mzee, Nahya Salim, Shubis Kafuruki, Maxmillian Mpina, Seif Shekalaghe, Marcel Tanner, Salim Abdulla
Malaria vaccines are considered amongst the most important modalities for potential elimination of malaria disease and transmission. Research and development in this field has been an area of intense...
Giuseppe Traversa, Stefania Spila-Alegiani, Clara Bianchi, Marta Ciofi degli Atti, Luisa Frova, Marco Massari, Roberto Raschetti, Stefania Salmaso, Gianpaolo Scalia Tomba
The signal of an association between vaccination in the second year of life with a hexavalent vaccine and sudden unexpected deaths (SUD) in the two days following vaccination was reported in Germany...
George E. Armah, Albert Z. Kapikian, Timo Vesikari, Nigel Cunliffe, Robert M. Jacobson, D. Bruce Burlington, Leonard P. Ruiz
Oral rhesus/rhesus-human reassortant rotavirus tetravalent (RRV-TV) vaccine was licensed in 1998 but withdrawn in 1999 due to a rare association with intussusception, which occurred...
Gary S. Marshall, Gregory L. Adams, Michael L. Leonardi, Maria Petrecz, Sheryl A. Flores, Angela L. Ngai, Jin Xu, Guanghan Liu, Jon E. Stek, Ginamarie Foglia, Andrew W. Lee
The safety and immunogenicity of DTaP5-IPV-Hib-HepB are comparable with the analogous licensed component vaccines. Decreased FHA GMCs and increased injection-site reactions and fever are unlikely to...
François Chappuis, Tiziana Farinelli, Henri Deckx, Michal Sarnecki, Oscar Go, Yvonne Salzgeber, Coby Stals
Purpose: This was a 20-year follow-up study to assess long-term persistence of protective antibody levels against the hepatitis A virus (HAV) in healthy participants vaccinated with 2 doses of...
Francisco Noya, Deirdre McCormack, Donna L. Reynolds, Dion Neame, Philipp Oster
To describe the immunogenicity and safety of a two-dose series of a quadrivalent meningococcal (serogroups A, C, Y and W) polysaccharide diphtheria toxoid conjugate vaccine (MenACYW-D) administered...
Firdausi Qadri, Fahima Chowdhury, Ashraful Islam Khan, Amit Saha, Iqbal Ansary Khan, Yasmin A. Begum, Taufiqur R. Bhuiyan, Mohiul Islam Chowdhury, Jasim Uddin, Jahangir A. M. Khan, Atique Iqbal Chowdhury, Anisur Rahman, Shah Alam Siddique, Muhammad Asaduzzaman, Afroza Akter, Arifuzzaman Khan, Young Ae You, Ashraf Uddin Siddik, Nirod Chandra Saha, Alamgir Kabir, Baizid Khoorshid Riaz, Shwapon Kumar Biswas, Farzana Begum, Leanne Unicomb, Stephen P. Luby, Alejandro Cravioto, John D. Clemens, Mohammad Ali
Cholera is endemic in Bangladesh with epidemics occurring each year. The decision to use a cheap oral killed whole-cell cholera vaccine to control the disease depends on the feasibility and...
Firdausi Qadri, Thomas F. Wierzba, Mohammad Ali, Fahima Chowdhury, Ashraful I. Khan, Amit Saha, M.Med , Iqbal A. Khan, Muhammad Asaduzzaman, M.Phil, Afroza Akter, Arifuzzaman Khan, Yasmin A. Begum, Taufiqur R. Bhuiyan, Farhana Khanam, Mohiul I. Chowdhury, Taufiqul Islam, Atique I. Chowdhury, Anisur Rahman, Shah A. Siddique, Young A. You, Deok R. Kim, Ashraf U. Siddik, Nirod C. Saha, Alamgir Kabir, Alejandro Cravioto, Sachin N. Desai, Ajit P. Singh, John D. Clemens
A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic...
Michael Favorov, Mohammad Ali, Aigul Tursunbayeva, Indira Aitmagambetova, Paul Kilgore, Shakhimurat Ismailov, Terence Chorba
Except during a 1-year period when BCG vaccine was not routinely administered, annual coverage of infants with Bacillus Calmette-Guérin (BCG) in Kazakhstan since 2002 has exceeded 95%. BCG...
Eyasu H. Teshale, Saleem Kamili, Jan Drobeniuc, Maxine Denniston, Barnabas Bakamutamaho, Robert Downing
Chronic hepatitis B virus infection (CHBI) is effectively prevented by vaccination starting at birth. Beginning in 2002 Uganda adopted a policy of providing the pentavalent hepatitis B vaccine...
Esther S. Pronker, Tamar C. Weenen, Harry Commandeur, Eric H. J. H. M. Claassen, Albertus D. M. E. Osterhaus
To date, vaccination is the most cost-effective strategy to combat infectious diseases. Recently, a productivity gap affects the pharmaceutical industry. The productivity gap describes the situation...
Sylvie Escolano, Catherine Hill, Pascale Tubert-Bitter
The increased risk of intussusception after vaccination with the rhesus-human reassortant rotavirus vaccine Rotashield led to its withdrawal in 2005. The researchers assess the risk of...
Ernesto Oviedo-Orta, Sohail Ahmed, Rino Rappuoli, Steven Black
Recently an investigational meningococcal B vaccine has been used in two college outbreaks in the US. This is the first time that a meningococcal B vaccine has been used for outbreak control in the...
Eric P. F. Chow, Jennifer A. Danielewski, Glenda Fehler, Sepehr N. Tabrizi, Matthew G. Law, Catriona S. Bradshaw, Suzanne M. Garland, Marcus Y. Chen, Christopher K. Fairley
The national quadrivalent human papillomavirus (4vHPV) vaccination programme was launched in Australia in April, 2007. In this study, the researchers aimed to explore the prevalence of...
Emmanuelle Varon, Robert Cohen, Stéphane Béchet, Catherine Doit, Corinne Levy
Highlights •Before and after PCV13 implementation, the ST relationship between carriage and IPD was investigated. •In children <2 years old, 569 IPD and 355 Sp isolated from 1212 healthy were...
Don L. Douglas, Denise A. DeRoeck, Richard T. Mahoney, Ole Wichmann
A face-to-face survey of 158 policymakers and other influential professionals was conducted in eight dengue-endemic countries in Asia (India, Sri Lanka, Thailand, Vietnam) and Latin America (Brazil,...
Donata Medaglini, Magdalena R De Azero, Odile Leroy, Florence Bietrix, Philippe Denoel
A clear vision for vaccines research and development (R&D) is needed if Europe is to continue to lead the discovery of next generation vaccines. Innovation Partnership for a Roadmap on Vaccines in...
Derek W. Cain, Sergio E. Sanders, Michael M. Cunningham, Garnett Kelsoe
Aluminum adjuvants, commonly referred to as “alum,” are the most widespread immunostimulants in human vaccines. Although the mechanisms that promote humoral responses to alum-adsorbed antigens...
Debajeet Choudhuri, Tanvir Huda, Evropi Theodoratou, Harish Nair, Lina Zgaga, Rachel Falconer, Ivana Luksic, Hope L. Johnson, Jian Shayne F. Zhang, Shams El Arifeen, Christopher B. Nelson, Ray Borrow, Harry Campbell, Igor Rudan
Meningococcal meningitis is a major cause of disease worldwide, with frequent epidemics particularly affecting an area of sub-Saharan Africa known as the “meningitis belt”. Neisseria meningitidis...
David A. Muller, Germain J. P. Fernando, Nick S. Owens, Christiana Agyei-Yeboah, Jonathan C. J. Wei, Alexandra C. I. Depelsenaire, Angus Forster, Paul Fahey, William C. Weldon, Oberste, Paul R. Young, Mark A. F. Kendall
To secure a polio-free world, the live attenuated oral poliovirus vaccine (OPV) will eventually need to be replaced with inactivated poliovirus vaccines (IPV). However, current IPV delivery is less...
Darin Zehrung, Courtney Jarrahian, Birgitte Giersing, Debra Kristensen
A variety of vaccine packaging and delivery technologies may benefit the immunization supply chain. These include alternative primary packaging, such as blow-fill-seal polymer containers, and novel...
John D. Clemens, Nguyen Tran Hien, Michael Favorov, Hye Jung Kwon, Jin Kyung Park, Tran Nhu Duong, Shannon L. Grahek, Vu Dinh Thiem, Anna Lena Lopez, Dang Duc Anh
Killed oral cholera vaccines (OCVs) are available but not used routinely for cholera control except in Vietnam, which produces its own vaccine. In 2007–2008, unprecedented cholera outbreaks...
World Health Organization (WHO), Gavi, the Vaccine Alliance, UNICEF, JSI, PATH
A guide to decide on adopting single dose schedule
Guide to support decision making on optimization of schedule, particularly single dose
World Health Organization (WHO)
Vaccines that use a multiple puncture technique are administered directly through the skin (i.e., percutaneous route) of the deltoid area on the upper arm with a sterile bifurcated needle. A...
Paul L. McCormack
Hexaxim(®) (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated...
World Health Organization (WHO)
This article presents the World Health Organization\'s (WHO) recommendations for the use of vaccines against Bordetella pertussis from the WHO position paper on Pertussis vaccines: WHO position...
R. Silberman, R. Normand, S. A. Klotz
A low rate of seroconversion to hepatitis B vaccine is reported. This occurred in healthy hospital employees from two separate institutions. A total of 236 individuals were evaluated in this study...
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West\'s...
Tomas Jelinek
The mosquito-borne Japanese encephalitis virus causes an estimated 50,000 cases in Asia, accounting for at least 10,000 deaths and 15,000 cases of neuropsychiatric sequelae. IXIARO® (Intercell AG,...
Courtney L. Davis, Rezwanul Wahid, Franklin R. Toapanta, Jakub K. Simon, Marcelo B. Sztein, Doron Levy
The researchers establish a mathematical framework for studying immune interactions with Shigella, a bacteria that kills over one million people worldwide every year. The long-term goal of this novel...
Tanya Clapp, Paul Siebert, Dexiang Chen, LaToya Jones Braun
Aluminum-containing adjuvants have been used to enhance the immune response against killed, inactivated, and subunit antigens for more than seven decades. Nevertheless, we are only beginning to gain...
Claire M. Tully, Teresa Lambe, Sarah C. Gilbert, Adrian V. S. Hill
The epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to...